Literature DB >> 8113399

Increased platelet deposition on atherosclerotic coronary arteries.

G H van Zanten1, S de Graaf, P J Slootweg, H F Heijnen, T M Connolly, P G de Groot, J J Sixma.   

Abstract

A ruptured atherosclerotic plaque leads to exposure of deeper layers of the plaque to flowing blood and subsequently to thrombus formation. In contrast to the wealth of data on the occurrence of thrombi, little is known about the reasons why an atherosclerotic plaque is thrombogenic. One of the reasons is the relative inaccessibility of the atherosclerotic plaque. We have circumvented this problem by using 6-microns cryostat cross sections of human coronary arteries. These sections were mounted on coverslips that were exposed to flowing blood in a rectangular perfusion chamber. In normal-appearing arteries, platelet deposition was seen on the luminal side of the intima and on the adventitia. In atherosclerotic arteries, strongly increased platelet deposition was seen on the connective tissue of specific parts of the atherosclerotic plaque. The central lipid core of an advanced plaque was not reactive towards platelets. The results indicate that the atherosclerotic plaque by itself is more thrombogenic than the normal vessel wall. To study the cause of the increased thrombus formation on the atherosclerotic plaque, perfusion studies were combined with immunohistochemical studies. Immunohistochemical studies of adhesive proteins showed enrichment of collagen types I, III, V, and VI, vitronectin, fibronectin, fibrinogen/fibrin, and thrombospondin in the atherosclerotic plaque. Laminin and collagen type IV were not enriched. von Willebrand Factor (vWF) was not present in the plaque. The pattern of increased platelet deposition in serial cross sections corresponded best with areas in which collagen types I and III were enriched, but there were also areas in the plaque where both collagens were enriched but no increased reactivity was seen. Inhibition of platelet adhesion with a large range of antibodies or specific inhibitors showed that vWF from plasma and collagen types I and/or III in the plaque were involved. Fibronectin from plasma and fibronectin, fibrinogen, laminin, and thrombospondin in the vessel wall had no effect on platelet adhesion. We conclude that the increased thrombogenicity of atherosclerotic lesions is due to changes in quantity and nature of collagen types I and/or III.

Entities:  

Mesh:

Year:  1994        PMID: 8113399      PMCID: PMC293885          DOI: 10.1172/JCI117014

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

1.  Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate--dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome.

Authors:  H J Weiss; V T Turitto; H R Baumgartner
Journal:  J Lab Clin Med       Date:  1978-11

2.  Platelet adherence to subendothelium of human arteries in pulsatile and steady flow.

Authors:  K S Sakariassen; P A Bolhuis; J J Sixma
Journal:  Thromb Res       Date:  1980 Aug 15-Sep 1       Impact factor: 3.944

3.  Subendothelial deposition of von Willebrand's factor requires the presence of endothelial cells.

Authors:  I I Sussman; J H Rand
Journal:  J Lab Clin Med       Date:  1982-10

4.  The distribution of collagen types I, III and V (AB) in normal and atherosclerotic human aorta.

Authors:  K G McCullagh; V C Duance; K A Bishop
Journal:  J Pathol       Date:  1980-01       Impact factor: 7.996

5.  Heavy metal intensification of DAB-based HRP reaction product.

Authors:  J C Adams
Journal:  J Histochem Cytochem       Date:  1981-06       Impact factor: 2.479

6.  The pathological basis and microanatomy of occlusive thrombus formation in human coronary arteries.

Authors:  M J Davies; T Thomas
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1981-08-18       Impact factor: 6.237

7.  Thrombin generation and fibrin formation following injury to rabbit neointima. Studies of vessel wall reactivity and platelet survival.

Authors:  H M Groves; R L Kinlough-Rathbone; M Richardson; L Jørgensen; S Moore; J F Mustard
Journal:  Lab Invest       Date:  1982-06       Impact factor: 5.662

8.  Serum spreading factor (vitronectin) is present at the cell surface and in tissues.

Authors:  E G Hayman; M D Pierschbacher; Y Ohgren; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.

Authors:  M A DeWood; J Spores; R Notske; L T Mouser; R Burroughs; M S Golden; H T Lang
Journal:  N Engl J Med       Date:  1980-10-16       Impact factor: 91.245

10.  Thrombogenicity of components of atheromatous material. An animal and in vitro model of cerebral atheroembolism.

Authors:  B J Jeynes; B A Warren
Journal:  Arch Pathol Lab Med       Date:  1981-07       Impact factor: 5.534

View more
  27 in total

1.  Platelet glycoprotein Ib alpha receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients.

Authors:  Dermot Kenny; Clare Muckian; Desmond J Fitzgerald; Christopher P Cannon; Denis C Shields
Journal:  J Thromb Thrombolysis       Date:  2002-02       Impact factor: 2.300

2.  Platelets, glycoprotein Ib-IX, and von Willebrand factor are required for FeCl(3)-induced occlusive thrombus formation in the inferior vena cava of mice.

Authors:  M V Joglekar; Jerry Ware; Jin Xu; Malinda E C Fitzgerald; Theodore Kent Gartner
Journal:  Platelets       Date:  2012-06-21       Impact factor: 3.862

3.  Structural insight into the role of thrombospondin-1 binding to calreticulin in calreticulin-induced focal adhesion disassembly.

Authors:  Qi Yan; Joanne E Murphy-Ullrich; Yuhua Song
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

4.  State of the art in platelet function testing.

Authors:  Beate E Kehrel; Martin F Brodde
Journal:  Transfus Med Hemother       Date:  2013-03-18       Impact factor: 3.747

5.  Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis.

Authors:  Hiroyasu Sato; Rina Kato; Yuki Isogai; Go-ichi Saka; Mitsuhiro Ohtsuki; Yoshitaka Taketomi; Kei Yamamoto; Kae Tsutsumi; Joe Yamada; Seiko Masuda; Yukio Ishikawa; Toshiharu Ishii; Tetsuyuki Kobayashi; Kazutaka Ikeda; Ryo Taguchi; Shinji Hatakeyama; Shuntaro Hara; Ichiro Kudo; Hiroyuki Itabe; Makoto Murakami
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

6.  Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agents.

Authors:  Jorge Magallon; Jianchun Chen; Leroy Rabbani; George Dangas; Jing Yang; James Bussel; Thomas Diacovo
Journal:  Circulation       Date:  2011-01-10       Impact factor: 29.690

7.  Imaging of atherosclerosis--a worthy challenge.

Authors:  H W Strauss
Journal:  J Nucl Cardiol       Date:  1996 May-Jun       Impact factor: 5.952

Review 8.  Developments in antithrombotic therapy: state of the art anno 1996.

Authors:  H ten Cate; M T Nurmohamed; J W ten Cate
Journal:  Pharm World Sci       Date:  1996-12

9.  Microfluidic devices for studies of shear-dependent platelet adhesion.

Authors:  Edgar Gutierrez; Brian G Petrich; Sanford J Shattil; Mark H Ginsberg; Alex Groisman; Ana Kasirer-Friede
Journal:  Lab Chip       Date:  2008-07-23       Impact factor: 6.799

10.  Neutrophil granulocyte-dependent proteolysis enhances platelet adhesion to the arterial wall under high-shear flow.

Authors:  N Wohner; Z Keresztes; P Sótonyi; L Szabó; E Komorowicz; R Machovich; K Kolev
Journal:  J Thromb Haemost       Date:  2010-04-20       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.